Leo Cancer Care Raises $65M for Upright Radiotherapy Platform

Leo Cancer Care, a Serra Capital III and Serra Capital III SBIC portfolio company, announced in early July that they have raised $65M to advance manufacturing and commercial deployment activities surrounding its upright radiotherapy platform.

The company’s oversubscribed Series D financing round was led by Yu Galaxy and had participation from Serra Ventures.

“For decades, the industry has tried to lower the cost of cancer care by making equipment cheaper and stripping out capability,” CEO Stephen Towe commented. “Our treatment approach is the opposite — to reimagine how care is delivered, designed around the patient rather than the machine, so advanced treatment can reach communities that never had access before, without compromising quality. This financing lets us accelerate that platform strategy across proton, photon and imaging.”

To view the complete press release, follow here.